An interventional study of Midpoint transverse process to pleura block and Erector spinae plane block in Midpoint Transverse Process to Pleura Block, Erector Spinae Plane Block and Acute Herpes Zoster, sponsored by Tanta University. Recruiting at 1 site in Egypt. Open to participants aged 21 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-07-29.
Sponsored by Tanta University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Pain by Tanta University — 10 open to participants now, 10 under way, 1 of them phase 3. Pain · Tanta University.
Among the 32 studies in Pain by Tanta University, this one is the 8th largest by planned enrollment, is one of 5 that started in 2026, is one of 30 with no phase, and was the 28th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →10 of the 32 studies in Pain by Tanta University are open now, in 1 country. Recruiting first, the newest first:
Tanta University · Sites in Egypt
Ages 18+
Tanta University · Sites in Egypt
Ages 50+
Tanta University · Sites in Egypt
Ages 21+
Tanta University · Sites in Egypt
Ages 5–7
Tanta University · Sites in Egypt
Ages 18+
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 21 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2020; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 70 across the 32 interventional studies. Of the 21 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Tanta University is the lead sponsor of 1,015 studies on the registry; 321 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
3 of the studies in Pain by Tanta University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07789340Tanta UniversityUnipolar Versus Bipolar Radiofrequency Ablation in Knee Osteoarthritis Pain | 2027-06-01 |
| NCT07732556Tanta UniversityMidpoint Transverse Process to Pleura (MTP) Block vs Erector Spinae Plane (ESP) Block for Acute Herpes Zoster (HZ) Pain | 2027-06-01 |
| NCT07853170Tanta University3-Needle vs 5-Needle of Genicular Nerve Block on Pain and Quality of Life in Knee Osteoarthritis | 2027-09-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 32 studies in Pain by Tanta University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to compare the analgesic efficacy and safety of ultrasound-guided midpoint transverse process block versus ultrasound-guided erector spinae plane block in patients suffering from thoracic herpes zoster pain.
Herpes zoster is caused by reactivation of latent varicella-zoster virus in dorsal root or cranial nerve ganglia and commonly presents with unilateral dermatomal rash associated with severe neuropathic pain.
The erector spinae plane block is an ultrasound-guided interfascial plane block in which local anesthetic is deposited deep to the erector spinae muscle adjacent to the transverse process, allowing multidermatomal spread and thoracic analgesia. Recent studies support its efficacy in herpes zoster pain management.
The midpoint transverse process to pleura block is a paravertebral-by-proxy technique where local anesthetic is injected midway between the posterior border of the transverse process and pleura. It may provide thoracic segmental analgesia with lower pleural puncture risk and easier sonoanatomy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will receive ultrasound-guided midpoint transverse process to pleura block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.
Other: Midpoint transverse process to pleura block
Patients will receive ultrasound -guided erector spinae plane block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.
Other: Erector spinae plane block
Patients will receive ultrasound-guided midpoint transverse process to pleura block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.
Patients will receive ultrasound -guided erector spinae plane block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.
Incidence of post-herpatic neuralgia
Incidence of post-herpatic neuralgia will be recorded after 12 weeks of block
Time frame: After 12 weeks of block
Blood pressure
Blood pressure will be recoded at time of block and following up at first 24 hours.
Time frame: 24 hours postoperatively
Heart rate
Heart rate will be recoded at time of block and following up at first 24 hours.
Time frame: 24 hours postoperatively
Oxygen saturation
Oxygen saturation will be recoded at time of block and following up at first 24 hours.
Time frame: 24 hours postoperatively
Time to first rescue analgesia
Time to first rescue analgesia will be recorded from the end of surgery till first dose of Acetaminophen administrated.
Time frame: 24 hours postoperatively
Total rescue analgesics consumption
Acetaminophen was offered on request as a rescue analgesic at a dosage of 1,000 mg. A maximum daily dosage of 4,000 mg will be permitted for people with Numerical Rating Scale (NRS)≥ 4.
Time frame: 24 hours postoperatively
Degree of pain
Pain intensity will be assessed using the Numerical Rating Scale (NRS), where 0 indicates no pain and 10 indicates the worst imaginable pain. NRS will be recorded at 30 minutes, 2 hours, 6 hours, 12 hours, 24 hours, after first 24 hours, 1 week, 2 weeks, 4 weeks, 8 weeks, and 12 weeks postoperatively
Time frame: 12 weeks postoperatively
Total anti-convulsant drugs
Total anti-convulsant drugs will be recorded at at 24 hours, 1 week, 2 weeks, 4 weeks, 8 weeks and 12 weeks postoperatively
Time frame: 12 weeks postoperatively
Assessment of sleep quality
The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report questionnaire will be used to assess the sleep quality. It evaluates seven clinical components: subjective sleep quality, sleep latency, duration, efficiency, disturbances, medication use, and daytime dysfunction. Each of the 7 components is scored on a scale from 0 to 3, where 0 indicates no difficulty and 3 indicates severe difficulty. Subjective Sleep Quality (Self-rated overall quality) Sleep Latency (Time it takes to fall asleep) Sleep Duration (Total hours slept per night) Habitual Sleep Efficiency (Percentage of time in bed spent asleep) Sleep Disturbances (Nighttime awakenings, breathing issues, etc.) Use of Sleeping Medication (Frequency of sleep aids) Daytime Dysfunction (Trouble staying awake or lack of enthusiasm during the day) ≤ 5: Indicates good sleep quality. \> 5: Indicates poor sleep quality.
Time frame: 12 weeks postoperatively
Incidence of complications
Incidence of complications such as pneumothorax, local anesthetic systemic toxicity, epidural spread, pleural puncture, and block failure will be recorded.
Time frame: 24 hours postoperatively
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
Started Jul 2026 (actual). Primary completion is estimated for Jun 2027, 11 months after the start.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 11 months is close to that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.